Tuesday, September 23, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Amgen Stock: Strong Earnings Overshadowed by Drug Doubts

Felix Baarz by Felix Baarz
August 6, 2025
in Stocks
0
Amgen Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Amgen reported stellar quarterly results, with revenue surging 9% to $9.2 billion—exceeding analyst expectations—and adjusted earnings per share jumping 21% to $6.02. The biotech giant also raised its full-year guidance, projecting revenue between $35-$36 billion and higher EPS estimates. However, shares fell nearly 5% as investor enthusiasm was dampened by concerns over its experimental weight-loss drug, MariTide. Analysts questioned its competitiveness against dominant rivals like Ozempic, casting doubt on Amgen’s ability to capitalize on this high-growth market.

Pipeline Performance Under Scrutiny

While drugs like cholesterol treatment Repatha saw sales soar 31% to $696 million, declining revenue for bone therapy Prolia (-4%) highlighted competitive pressures. Despite heavy R&D investment (up 18%), MariTide remains a key uncertainty, with critical trial data expected later this year. The stock, though up 10% year-to-date, lags behind broader indices, reflecting deeper skepticism about Amgen’s long-term growth strategy amid shifting market dynamics.

Ad

Amgen Stock: Buy or Sell?! New Amgen Analysis from September 23 delivers the answer:

The latest Amgen figures speak for themselves: Urgent action needed for Amgen investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 23.

Amgen: Buy or sell? Read more here...

Tags: Amgen
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Quantum Computing Stock
Stocks

Quantum Computing Stock Dips Despite Major Contract Wins

September 16, 2025
Coinbase Stock
Stocks

Institutional Partnership Fuels Optimism for Coinbase’s Future

September 16, 2025
Strategy Stock
Stocks

MicroStrategy’s Bitcoin Bet Faces Market Skepticism

September 16, 2025
Next Post
Onward MedicalV Stock

Onward MedicalV Stock: Neurotech Firm Taps Medtech Veteran for Growth

NiSource Stock

NiSource Stock: Strong Earnings Beat Amid Cautious Market Reaction

General Motors Stock

General Motors Stock: Strategic Shifts Boost Market Confidence

Recommended

Analyst Reaffirms Bullish Outlook on Genius Sports

2 years ago
Electric Utilities Stock Bull Market

Analyst Reiterates EqualWeight Rating on Xcel Energy with Revised Price Target

2 years ago
TSMC Stock

TSMC Faces Security Crisis as Employees Charged with Stealing Advanced Chip Technology

4 weeks ago

NeoGames SA Partners with Georgia Lottery Corporation to Introduce Premium eInstants

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Unlikely Endorsement Fuels Speculative Frenzy in Krispy Kreme Shares

Nio’s Production Struggles Amid Overwhelming ES8 Demand

Leadership Shakeup and Major Restructuring at Procter & Gamble

Astria Therapeutics Gains Momentum with Promising Eczema Treatment Data

An Unconventional 12% Yield Strategy in the Tech Sector

Liberty Broadband’s Future Hinges on Pending Charter Merger

Trending

Lindblad Expeditions Stock
Analysis

Lindblad Expeditions Shares Stagnate Despite Strong Travel Sector

by Andreas Sommer
September 23, 2025
0

The stock of luxury travel provider Lindblad Expeditions appears to be trapped in a holding pattern. For...

Digimarc Stock

Digimarc Shares Exhibit Strong Gains Amidst High Volatility Concerns

September 23, 2025
Kimball Electronics Stock

Medical Technology Drives Kimball Electronics’ Strategic Growth

September 23, 2025
Krispy Kreme Stock

Unlikely Endorsement Fuels Speculative Frenzy in Krispy Kreme Shares

September 23, 2025
Nio Stock

Nio’s Production Struggles Amid Overwhelming ES8 Demand

September 23, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lindblad Expeditions Shares Stagnate Despite Strong Travel Sector
  • Digimarc Shares Exhibit Strong Gains Amidst High Volatility Concerns
  • Medical Technology Drives Kimball Electronics’ Strategic Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com